| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 137, 1033-1045, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
L Claudio, Y Kress, J Factor and CF Brosnan
Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461.
Most of the central nervous system (CNS) endothelium regulates the passage of solutes and functions as a blood-brain barrier (BBB). During experimental autoimmune encephalomyelitis (EAE), an inflammatory demyelinating disease of the CNS, loss of BBB function occurs. The authors have previously shown an increase in endothelial transcytotic activity associated with decreased mitochondrial content as evidence of BBB dysfunction in EAE. These changes occurred in the capillary bed and correlated with CNS edema and clinical signs. In the present report, a fixation procedure before infusion of the intravascular tracer horseradish peroxidase (HRP) in rats at the height of clinical EAE has been used. In these animals, tracer leakage was only noted in inflamed venules with diameters of 12 to 19 mu. The authors detected several mechanisms of passive leakage: 1) increased junctional permeability; 2) increased interendothelial space; 3) leakage alongside migrating inflammatory cells. Some small capillaries showed necrotic changes with minimal tracer leakage. This report demonstrates that BBB disruption also occurs via nonendocytic mechanisms that may be induced by inflammatory cells.
This article has been cited by other articles:
 |
|
 |
|
  B. A. t Hart, H. P. M. Brok, E. Remarque, J. Benson, G. Treacy, S. Amor, R. Q. Hintzen, J. D. Laman, J. Bauer, and E. L. A. Blezer Suppression of Ongoing Disease in a Nonhuman Primate Model of Multiple Sclerosis by a Human-Anti-Human IL-12p40 Antibody J. Immunol., October 1, 2005; 175(7): 4761 - 4768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. LEVINE and A. CHAKRABARTY The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 252 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lutton, R. Winston, and T. C. Rodman Multiple Sclerosis: Etiological Mechanisms and Future Directions Experimental Biology and Medicine, January 1, 2004; 229(1): 12 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Chakrabarty, M R Emerson, and S M LeVine Hemeoxygenase-1 in SJL mice with experimental allergic encephalomyelitis Multiple Sclerosis, August 1, 2003; 9(4): 372 - 381. [Abstract] [PDF]
|
|
|
|
 |
|
 N. R. Sibson, A. M. Blamire, V. H. Perry, J. Gauldie, P. Styles, and D. C. Anthony TNF-{alpha} reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway Brain, November 1, 2002; 125(11): 2446 - 2459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Westland, J. D. Pollard, S. Sander, J. G. Bonner, C. Linington, and J. G. McLeod Activated non-neural specific T cells open the blood–brain barrier to circulating antibodies Brain, July 1, 1999; 122(7): 1283 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Becker, R. M. McCarron, C. Ruetzler, O. Laban, E. Sternberg, K. C. Flanders, and J. M. Hallenbeck Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia PNAS, September 30, 1997; 94(20): 10873 - 10878. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
